Teaching Old Drugs New Tricks: Statins for COVID-19?

The COVID-19 pandemic has driven unprecedented efforts to identify existing treatments that can be quickly and effectively repurposed to reduce morbidity and mortality. In this issue of Cell Metabolism, Zhang et al. (2020) report an association between statin use and improved outcomes in a large obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Fajgenbaum, David C., Rader, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402379/
https://www.ncbi.nlm.nih.gov/pubmed/32755604
http://dx.doi.org/10.1016/j.cmet.2020.07.006
Descripción
Sumario:The COVID-19 pandemic has driven unprecedented efforts to identify existing treatments that can be quickly and effectively repurposed to reduce morbidity and mortality. In this issue of Cell Metabolism, Zhang et al. (2020) report an association between statin use and improved outcomes in a large observational study of hospitalized COVID-19 patients. Given the widespread availability, low cost, and safety of statins, this promising result should be further investigated in randomized controlled trials.

Ejemplares similares